# Does it Matter the Volume of Injectate on the Outcome of Ultrasound-guided Perineural Injection for Carpal Tunnel Syndrome

> **NCT07283874** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 35 (estimated)

## Conditions studied

- Carpal Tunnel Syndrome (CTS)

## Interventions

- **DRUG:** Dextrose 5%
- **DRUG:** Dextrose 5%
- **DRUG:** Triamcinolone Acetonide (Aristocort® C)
- **DRUG:** Lidocaine 2 %

## Key facts

- **NCT ID:** NCT07283874
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07283874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07283874, "Does it Matter the Volume of Injectate on the Outcome of Ultrasound-guided Perineural Injection for Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07283874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*